Antiangiogenic Properties of Axitinib versus Sorafenib Following Sunitinib Resistance in Human Endothelial Cells—A View towards Second Line Renal Cell Carcinoma Treatment

por Juengel, Eva, Schnalke, Pascal, Rutz, Jochen, Maxeiner, Sebastian, Chun, Felix K.-H., Blaheta, Roman A.
Publicado 2021